Prevalence of IgG antibodies induced by the SARS‐COV‐2 virus in asymptomatic adults in Nuevo Leon, Mexico
Authors:
- Edgar P. Rodríguez‐VidalesEREdgar P. Rodríguez‐Vidales
- Denise Garza‐CarrilloDGDenise Garza‐Carrillo
- José J. Pérez‐TrujilloJPJosé J. Pérez‐Trujillo
- Olivia A. Robles‐RodríguezOROlivia A. Robles‐Rodríguez
- Ana María Salinas‐MartínezASAna María Salinas‐Martínez
- Roberto Montes de Oca‐LunaRORoberto Montes de Oca‐Luna
- Consuelo Treviño‐GarzaCTConsuelo Treviño‐Garza
- Manuel E. De la O‐CavazosMOManuel E. De la O‐Cavazos
Open Access
- 7 June 2021
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 93 (10) , 5873-5879
Abstract
Population‐based immunoglobulin G (IgG) seroprevalence studies in asymptomatic individuals in Latin America are scarce. The objective of the study was to estimate the prevalence and geographic distribution of IgG antibodies induced by natural SARS‐CoV‐2 infection in asymptomatic adults, 5–8 months after the first case was reported in a northeastern state of Mexico. This was a population‐based cross‐sectional study carried out in Nuevo Leon during August–November 2020. Individuals ≥18 years with no previous diagnosis or symptoms suggestive of COVID‐19 were consecutively screened in one of the busiest subway stations. Also, a search for eligible individuals was done from house‐to‐house, after selecting densely populated geographic sectors of each of the municipalities of the metropolitan area (n = 4495). The IgG antibodies to SARS‐CoV‐2 nucleocapsid protein were analyzed. The IgG antibody positivity rate was 27.1% (95% confidence interval [CI]: 25.8, 28.4); there were no differences by sex or age (p > 0.05). Analysis by month showed a gradual increase from 11.9% (August) to 31.9% (November); Week 39 had the highest positivity rate (42.2%, 95% CI: 34.2, 50.7). Most people did not have evidence of previous SARS‐CoV‐2 infection. Preventive measures and promotion of the COVID‐19 vaccine should be strengthened.Keywords
This publication has 20 references indexed in Scilit:
- Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican RepublicThe American Journal of Tropical Medicine and Hygiene, 2020
- The Power of Antibody-Based SurveillanceNew England Journal of Medicine, 2020
- Rapid Antibody-Based COVID-19 Mass Surveillance: Relevance, Challenges, and Prospects in a Pandemic and Post-Pandemic WorldJournal of Clinical Medicine, 2020
- Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, BrazilRevista Panamericana de Salud Pública, 2020
- Transmission of SARS-CoV-2 in Public Transportation Vehicles: A Case Study in Hunan Province, ChinaOpen Forum Infectious Diseases, 2020
- Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19New England Journal of Medicine, 2020
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological studyThe Lancet, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet, 2020
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoJournal of Clinical Microbiology, 2020
- The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countriesPLOS ONE, 2020